Home Health Why NAFDAC recalled Dove Beauty Cream Bar Soap
Health

Why NAFDAC recalled Dove Beauty Cream Bar Soap

Share
Share

By Chioma Obinagwam

The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public about the recall of Dove Beauty Cream Bar Soap (100g) with batch number 81832M 08, produced in Germany, due to chemical impurity.

Confiance News gathered from on Friday.

“The product does not comply with the Cosmetic Products Regulation as it is said to contain Butylphenyl Methylpropional (BMHCA) which is prohibited in cosmetic products due to its risk of harming the reproductive system, causing harm to the health of an unborn child and may cause skin sensitization. As a result, a ban on the marketing of the product has been placed by some regulatory and public authorities, in the EU,” NAFDAC said.

Here are details of the product:

The details of the product are as follows.

Product Name: Dove Beauty Cream Bar Soap

Product Brand: Dove

Country of Manufacture: Germany

Bar Code Number: 8000700000005

Category: Cosmetics

Product Photo:

Photo credit: NAFDAC

Confiance News learnt that other Dove cosmetic products recalled/banned in other countries due to presence of Butylphenyl Methylpropional are as follows; See link:

https://nafdac.gov.ng/public-alert-no-035-2024-alert-on-the-recall-of-dove-beauty-cream-bar-soap-due-to-butyphenyl-methylpropional-bmhca-content/

Importation of soaps, it says, is prohibited in Nigeria as per the restricted and import prohibition list. Beyond the import restrictions soaps and cosmetics are parts of the items ineligible for foreign exchange to import in Nigeria.

“These products are also not available in the NAFDAC database. Importers, distributors, retailers and consumers are advised to exercise caution and vigilance within the supply chain to avoid the importation, distribution, sale and use of the above-mentioned products. Members of the public in possession of the product should discontinue the sale or use and submit stock to the nearest NAFDAC office.

“Healthcare professionals and consumers are encouraged to report adverse events experienced with the use of regulated products to the nearest NAFDAC office, via pharmacovigilance@nafdac.gov.ng, E-reporting platforms available at www.nafdac.gov.ng,” it advised.

Please follow and like us:
Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Member

Don't Miss

‎CBN’s new cash policy: A welcome liberalisation or risky retreat?‎

By Blaise Udunze‎‎ On December 2, 2025, the Central Bank of Nigeria (CBN) announced a policy that significantly departs from the cash-restriction measures...

‎Arthur Stevens CEO Olatunde Amolegbe to Deliver Keynote on AI, digital economy at Business Journal annual lecture 2025‎

By Chioma Obinagwam‎‎ Olatunde Amolegbe, Managing Director and CEO of Arthur Stevens Asset Management Limited, has been announced as the keynote speaker for...

Related Articles

‎Is tear gas really just a harmless crowd control tool? What authorities don’t tell you

‎By Chioma Obinagwam ‎Tear gas, a staple in riot suppression, is not...

‎Awba-Ofemili to host 2025 community health campaign on Buruli Ulcer‎

‎By Chioma Obinagwam‎‎The Awba-Ofemili Development Union (ADU) Health Committee, in partnership with...

‎Thousands unite for Sickle Cell awareness in memory of Dr. Akiyode

‎By Chioma Obinagwam ‎On October 8, 2025, the Olufunke Akiyode Sickle Cell...

‎WHO declares ebola outbreak in Congo’s Kasai Province

By Chioma Obinagwam‎‎On September 4, 2025, the Democratic Republic of the Congo...